IRIS
CROTTI, LIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.548
AS - Asia 4.321
EU - Europa 3.489
SA - Sud America 524
Continente sconosciuto - Info sul continente non disponibili 188
AF - Africa 152
OC - Oceania 43
Totale 15.265
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.278
CN - Cina 2.135
SG - Singapore 936
IE - Irlanda 802
IT - Italia 502
HK - Hong Kong 450
UA - Ucraina 389
RU - Federazione Russa 370
DE - Germania 369
BR - Brasile 361
VN - Vietnam 360
FI - Finlandia 353
FR - Francia 209
GB - Regno Unito 203
CA - Canada 137
SE - Svezia 107
BD - Bangladesh 106
IN - India 85
ZA - Sudafrica 79
AR - Argentina 67
IQ - Iraq 41
MX - Messico 38
BE - Belgio 35
JP - Giappone 31
PL - Polonia 27
CO - Colombia 24
EC - Ecuador 24
AT - Austria 23
NZ - Nuova Zelanda 23
NL - Olanda 22
PK - Pakistan 20
AU - Australia 19
TR - Turchia 19
PH - Filippine 17
VE - Venezuela 17
ES - Italia 16
MA - Marocco 16
CR - Costa Rica 15
KE - Kenya 12
MY - Malesia 12
SV - El Salvador 12
UZ - Uzbekistan 12
TN - Tunisia 11
TT - Trinidad e Tobago 11
CL - Cile 10
SA - Arabia Saudita 10
GP - Guadalupe 9
ID - Indonesia 9
IL - Israele 9
JM - Giamaica 9
JO - Giordania 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
CW - ???statistics.table.value.countryCode.CW??? 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
ET - Etiopia 7
KR - Corea 7
KZ - Kazakistan 7
NI - Nicaragua 7
PE - Perù 7
PR - Porto Rico 7
RO - Romania 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
EG - Egitto 6
EU - Europa 6
IR - Iran 6
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
DK - Danimarca 5
GT - Guatemala 5
KG - Kirghizistan 5
NP - Nepal 5
PY - Paraguay 5
GR - Grecia 4
HN - Honduras 4
LT - Lituania 4
LU - Lussemburgo 4
PT - Portogallo 4
BB - Barbados 3
LV - Lettonia 3
OM - Oman 3
PA - Panama 3
TH - Thailandia 3
BS - Bahamas 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LY - Libia 2
NO - Norvegia 2
QA - Qatar 2
UY - Uruguay 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
Totale 15.071
Salva come PNG Salva come JPEG
Città #
Dublin 799
Chandler 708
San Jose 570
Ashburn 559
Jacksonville 496
Singapore 477
Hong Kong 440
Nanjing 436
Beijing 393
Dallas 392
Council Bluffs 357
Boardman 207
Nanchang 172
Wilmington 146
Ho Chi Minh City 141
Princeton 140
Los Angeles 139
Lawrence 138
Shenyang 135
Lauterbourg 129
Changsha 121
Helsinki 120
Hebei 119
Ann Arbor 118
New York 116
Milan 109
Jiaxing 108
Medford 97
Hanoi 83
Johannesburg 72
Hangzhou 71
Shanghai 71
Pavia 66
Tianjin 63
Buffalo 62
Redondo Beach 61
Moscow 59
Munich 49
Toronto 49
Santa Clara 45
São Paulo 40
Woodbridge 37
Frankfurt am Main 32
Houston 32
Orem 31
Tokyo 31
Brussels 29
Seattle 29
Norwalk 28
Atlanta 27
Verona 25
Nuremberg 24
Denver 23
Falkenstein 23
Brooklyn 22
Chicago 22
Fairfield 22
London 22
Turku 21
Warsaw 21
Des Moines 19
Ottawa 19
Baghdad 18
San Francisco 18
Zhengzhou 18
Chennai 17
Phoenix 17
Kunming 16
Manchester 16
The Dalles 16
Boston 15
Columbus 15
Montreal 15
Trieste 15
Falls Church 14
Haiphong 14
Naples 14
Rome 14
Florence 13
Guangzhou 13
Bergamo 12
City of London 12
Pune 12
San José 12
Stockholm 12
Amsterdam 11
Dunedin 11
Jinan 11
Nairobi 11
Tashkent 11
Mexico City 10
Miami 10
Rochester 10
Belo Horizonte 9
Brasília 9
Buenos Aires 9
Da Nang 9
Dhaka 9
Hải Dương 9
Piscataway 9
Totale 9.698
Salva come PNG Salva come JPEG
Nome #
Mapping the human genetic architecture of COVID-19 312
A first update on mapping the human genetic architecture of COVID-19 229
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 199
Long QT and short QT syndromes. 183
FGF12 is a candidate Brugada syndrome locus. 161
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 160
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 156
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 148
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 147
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 145
Gene symbol: KCNH2 144
Long QT syndrome-associated mutations in intrauterine fetal death. 139
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 139
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 136
The genetics underlying acquired long QT syndrome: impact for genetic screening. 135
AKAP9 is a genetic modifier of congenuital Long-QT Syndrome type 1 133
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 131
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 127
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 126
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 124
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 124
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 124
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 123
Cardiac potassium channel dysfunction in sudden infant death syndrome. 122
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 122
Inherited cardiac arrhythmia syndrome. Role of potassium channels 120
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 120
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. 120
All LQT3 patients need an ICD. True or false? 119
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 119
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 119
Cardiac sodium channel dysfunction in sudden infant death syndrome. 118
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 118
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 117
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 117
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 116
QT lungo, sindrome del 116
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 114
Prevalence of the congenital long-QT syndrome. 114
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 114
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: validation of the 2013 diagnostic criteria. 113
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 113
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 111
A Refined Multiscale Self-Entropy Approach for the Assessment of Cardiac Control Complexity: Application to Long QT Syndrome Type 1 Patients 111
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 110
The ICD for the long QT syndrome: which indications, complications, and results? 109
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. 109
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 109
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. 109
NOS1AP Is a Genetic Modifier of the Long-QT Syndrome 108
Can a message from the dead save lives? 108
Brugada and Long QT Syndrome are two different diseases: True or False? 108
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes, Transgenic Rabbits, and Patients 107
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 106
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 105
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. 104
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms. 103
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant. 103
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 103
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome. 103
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 103
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 103
Congenital long QT and short QT syndromes 102
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 102
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 102
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 101
Filtering approach based on empirical mode decomposition improves the assessment of short scale complexity in long QT syndrome type 1 population 100
Idiopathic Ventricular Fibrillation. 99
Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical Features 99
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications]. 98
Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. 98
Gene symbol: SCN5A 97
The Long QT Syndrome 96
QTc behavior during exercise and genetic testing for the long-QT syndrome. 96
Novel calmodulin mutations associated with congenital arrhythmia susceptibility. 96
Functional characterization and molecular correction of the LQT2 KCNH2-Q376 splicing mutation. Therapeutic implications? 95
Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. 95
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. 95
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 94
Gene symbol: KCNH2 94
Clinical implications for patients with Long QT Syndrome who experience a cardiac event during infancy 94
Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study. 94
Calmodulin mutations associated with recurrent cardiac arrest in infants. 94
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation. 94
Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy. 94
Mutation-specific risk in two genetic forms of type 3 long QT syndrome. 93
Gene symbol: KCNH2 93
Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients. 93
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6) 92
High efficacy of beta-blockers in Long QT Syndrome type 1: contribution of non-compliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”. 92
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. 91
Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome 90
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. 89
Gene symbol: KCNH2. 89
Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. 89
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. 89
Symbolic analysis of heart period and QT interval variabilities in LQT1 patients 89
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 89
Refined multiscale entropy analysis of heart period and QT interval variabilities in long QT syndrome type-1 patients2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 86
Gene expression and arrhythmic risk. 86
Totale 11.487
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.697
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022519 0 0 0 0 13 18 7 43 34 6 90 308
2022/20232.247 232 152 27 246 194 221 2 108 907 6 124 28
2023/2024820 92 136 22 53 73 196 23 77 5 30 65 48
2024/20252.079 45 178 62 51 46 116 103 174 526 74 220 484
2025/20264.779 376 391 519 429 622 202 878 225 426 330 206 175
2026/20271.300 103 303 364 519 11 0 0 0 0 0 0 0
Totale 15.265